Concepedia

Jonathan Busquets

JB

Statistics

Publications

4

Citations

112

H-Index

4

Active since

2021

Affiliations

The University of Texas at Austin(Current)

Livestrong Foundation

The University of Texas MD Anderson Cancer Center

Jonathan Busquets is an author at The University of Texas at Austin specializing in medicine, pharmacology, and chemotherapy.

ORCID

Publications per year

2021–2024

4

Publications

4

SLC25A51 decouples the mitochondrial NAD+/NADH ratio to control proliferation of AML cells

Mu‐Jie Lu, Jonathan Busquets, Valeria Impedovo et al. · Cell Metabolism · 2024 · 40 citations · Full text

, , +14

Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses

Courtney D. DiNardo, Divij Verma, Natalia Baran et al. · Nature Cancer · 2024 · 36 citations

, , +5

The Combined Treatment With the FLT3-Inhibitor AC220 and the Complex I Inhibitor IACS-010759 Synergistically Depletes Wt- and FLT3-Mutated Acute Myeloid Leukemia Cells

Xiyuan Lu, Lina Han, Jonathan Busquets et al. · Frontiers in Oncology · 2021 · 18 citations · Full text

, , +16

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

Katie Hege-Hurrish, Yongwei Su, Shraddha Patel et al. · Biochemical Pharmacology · 2023 · 18 citations · Full text

, , +5

1–4 of 4